ப்ரீஶியந்ஸ் பாயஂட் மூலதனம் மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரீஶியந்ஸ் பாயஂட் மூலதனம் மேலாண்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரீஶியந்ஸ் பாயஂட் மூலதனம் மேலாண்மை Today - Breaking & Trending Today

Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting


Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting
Sends Letter to Fellow MiMedx Shareholders Citing Board s Failure to Maximize Shareholder Value
News provided by
Share this article
Share this article
BATON ROUGE, La., April 16, 2021 /PRNewswire/  Prescience Point Capital Management, together with its affiliates ( Prescience Point ), a research-focused, catalyst-driven investment firm, announced today the nomination of four highly qualified director candidates to the Board of Directors (the Board ) of MiMedx Group, Inc. (NASDAQ: MDXG) ( MiMedx or the Company ). Prescience Point, a beneficial owner of approximately 8.1% of the outstanding shares of MiMedx, believes that the best path forward for unlocking shareholder value is the addition of Mr. Eiad Asbahi, Mr. Alfred G. Merriweather, Ms. Charlotte E. Sibley, and Mr. William F. Spengler to the Board at the upcoming Annual Meetin ....

Eiad Asbahi , Charlottee Sibley , Williamf Spengler , Alfredg Merriweather , Mimedx Group Inc , Company Board Of Directors The , Prescience Point Capital Management , Mimedx Group , Prescience Point , Annual Meeting , Managing Partner , Fellow Mimedx Shareholders , Point Capital Management , Game Changing Product Remains Hidden , Resulting In Chronic , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் தி , ப்ரீஶியந்ஸ் பாயஂட் மூலதனம் மேலாண்மை , ப்ரீஶியந்ஸ் பாயஂட் , ஆண்டு சந்தித்தல் , நிர்வகித்தல் கூட்டாளர் , பாயஂட் மூலதனம் மேலாண்மை ,

Prescience Point Capital Management Raises Price Target on MiMedx Group to $31 Per Share


Prescience Point Capital Management Raises Price Target on MiMedx Group to $31 Per Share
New Research Indicates That MiMedx s Amniofix Injectable Product Will Be A Blockbuster, Game-Changing Treatment for Knee Osteoarthritis
MiMedx s Wound Care Sales Are Poised To Re-Accelerate Over The Coming Quarters Due To Recent Contract And Insurance Wins And A New Product Launch
News provided by
Share this article
Share this article
BATON ROUGE, La., Dec. 16, 2020 /PRNewswire/  Prescience Point Capital Management, a research-focused, catalyst-driven investment firm, today announced it has issued new research on MiMedx Group Inc. (Nasdaq: MDXG), raising the price target on the leading advanced wound care and therapeutic biologics company to $31 per share. Prescience Point is one of the company s largest shareholders, owning 9 million or approximately 6.5% of the fully-diluted common stock of MiMedx. ....

Eiad Asbahi , Mimedx Amniofix , Prescience Investment Group , Mimedx Group Inc , Financial Industry Regulatory Authority , Prescience Point Capital Management , Mimedx Group , Prescience Point , Managing Partner , Point Capital Management , Baton Rouge , Investment Group , Point Capital , ப்ரீஶியந்ஸ் முதலீடு குழு , நிதி தொழில் ஒழுங்குமுறை அதிகாரம் , ப்ரீஶியந்ஸ் பாயஂட் மூலதனம் மேலாண்மை , ப்ரீஶியந்ஸ் பாயஂட் , நிர்வகித்தல் கூட்டாளர் , பாயஂட் மூலதனம் மேலாண்மை , தடியடி ரூஜ் , முதலீடு குழு , பாயஂட் மூலதனம் ,